Bio-techne Invest Advisor

Bio-Techne Co. (NASDAQ:TECH) Receives Consensus Rating of 'Moderate Buy' from Analysts Feb 18, 2025

Bio-Techne Q1 2025 Earnings Preview Oct 30, 2024